DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
VanCutsem E, D’Haens G. et al.
KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience. ASCO Ann Meet Proc.
J Clin Oncol 2008; 26: 18S (Abstr 2)-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.